Stay updated on Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Sign up to get notified when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Updated page revision from v3.3.3 to v3.3.4 with no visible impact on content or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T04:05:13.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The study's Locations section has been expanded and reorganized to list participating sites across multiple countries and regions.
    Difference
    3%
    Check dated 2025-12-23T21:19:31.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The Publications section now notes that PubMed publications are automatically populated and may not be about the study. The revision label changed from v3.2.0 to v3.3.2.
    Difference
    0.0%
    Check dated 2025-11-25T10:40:10.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Notice about government funding and NIH operating status was removed from the page's deletions section, with no changes to the study data or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-18T06:56:31.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The new screenshot shows only minor user-interface adjustments, such as spacing and header alignment, with no changes to core trial information. There are no edits to the study title, conditions, interventions, eligibility criteria, enrollment, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T20:58:24.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    2%
    Check dated 2025-10-06T05:25:16.000Z thumbnail image

Stay in the know with updates to Tivozanib vs Sorafenib in Refractory RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tivozanib vs Sorafenib in Refractory RCC Clinical Trial page.